Udg Healthcare PLC (LON:UDG) had its target price lifted by Berenberg Bank from GBX 655 ($8.55) to GBX 700 ($9.14) in a report issued on Friday morning. The firm currently has a buy rating on the stock.

A number of other analysts have also recently issued reports on the company. Jefferies Group raised their price objective on Udg Healthcare PLC from GBX 680 ($8.88) to GBX 720 ($9.40) and gave the company a buy rating in a research report on Friday, September 30th. Stifel Nicolaus reaffirmed a hold rating and issued a GBX 620 ($8.09) price objective on shares of Udg Healthcare PLC in a research report on Wednesday, September 28th. Numis Securities Ltd reissued an add rating and set a GBX 675 ($8.81) price target on shares of Udg Healthcare PLC in a report on Wednesday, September 28th. Goodbody reissued a buy rating on shares of Udg Healthcare PLC in a report on Thursday, August 4th. Finally, Davy Research reissued an outperform rating on shares of Udg Healthcare PLC in a report on Thursday, August 4th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of GBX 666 ($8.69).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Shares of Udg Healthcare PLC (LON:UDG) traded up 0.24% during mid-day trading on Friday, reaching GBX 635.50. The company’s stock had a trading volume of 244,459 shares. The firm has a 50 day moving average price of GBX 632.06 and a 200 day moving average price of GBX 603.04. The firm’s market cap is GBX 1.56 billion. Udg Healthcare PLC has a 52-week low of GBX 452.20 and a 52-week high of GBX 663.00.

In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the firm’s stock in a transaction on Monday, September 26th. The stock was sold at an average price of GBX 634 ($8.28), for a total transaction of £575,982.66 ($751,837.44).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Stock Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related stocks with our FREE daily email newsletter.